Terms: = Thyroid cancer AND MKL1, BSAC, 57591, ENSG00000196588, Q969V6, MRTF-A AND Treatment
3 results:
1. MKL-1 suppresses ferroptosis by activating system Xc- and increasing glutathione synthesis.
Dai ZT; Wu YL; Li XR; Liao XH
Int J Biol Sci; 2023; 19(14):4457-4475. PubMed ID: 37781038
[TBL] [Abstract] [Full Text] [Related]
2. mkl1 overexpression predicts poor prognosis in patients with papillary thyroid cancer and promotes nodal metastasis.
Cheng X; Xu S; Pan J; Zheng J; Wang X; Yu H; Bao J; Xu Y; Guan H; Zhang L
J Cell Sci; 2019 Aug; 132(16):. PubMed ID: 31363007
[TBL] [Abstract] [Full Text] [Related]
3. miR-206 inhibits metastasis-relevant traits by degrading mrtf-a in anaplastic thyroid cancer.
Zhang WL; Lv W; Sun SZ; Wu XZ; Zhang JH
Int J Oncol; 2015 Jul; 47(1):133-42. PubMed ID: 25955685
[TBL] [Abstract] [Full Text] [Related]
